Delivery Order SPE2DR25D3013-SPE2DR26F6T7C
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $98,000 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units). This competitive, firm fixed-price delivery order was issued on December 4, 2025, with an ultimate completion date of December 26, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $27,946.94 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) on December 4, 2025, with an ultimate completion date of December 26, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $13,973.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 30, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for $13,973.47 to supply Scemblix 40 mg tablets (60-count units) with a completion date of December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as the vendor's...
- The Defense Logistics Agency (DLA) awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Scemblix 40 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp for Scemblix 40 mg tablets (60-count units) on August 8, 2025, with an ultimate completion date of August 29, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $27,946.94 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets (60-count units) on November 18, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $69,851.01 to AmerisourceBergen Drug Corp for Scemblix 40 mg tablets (60-count units) with a firm fixed price structure. The delivery order, issued on December 2, 2025, with completion targeted for December 23, 2025, represents a non-competitive, non-set-aside award to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $13,973.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Scemblix 40 mg tablets (60-count unit of use packaging). This non-set-aside contract is scheduled for completion by December 22, 2025, and represents a single delivery order fulfillment from AmerisourceBergen's extensive pharmaceutical supply portfolio. The place of performance is located at the company's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Scemblix 40 mg tablets (60-count unit doses) with a ceiling value of $13,259.50. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be...
- SPE2DR25D3013Indefinite Delivery Contract
- SPE2DR25D3013-SPE2DR26F6T7CDelivery Order
The Defense Logistics Agency (DLA) awarded a $13,973.47 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Scemblix (40 mg tablets) in quantities of 60s. The contract represents a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded without set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard. The company's substantial IDC enables flexible fulfillment of diverse pharmaceutical needs across multiple therapeutic domains to support military personnel and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 12/1/25 |